Management Team

An Cerdobbel joined 272Bio in 2021 as a CMC Subject Matter Expert. An received a PhD in Bioscience Engineering from Ghent University (2010) for work performed in the field of applied biocatalysis. She then moved to Ablynx, where she was quickly promoted from Associate Scientist over Senior Scientist to Team Lead within the Analytical Department.

She closely collaborated with discovery, USP/DSP and contract manufacturing, which gave her a very broad view of biopharmaceutical development in general and of single domain antibodies in particular. After a brief stint in Market Access (by then in the holding of Sanofi), she was recruited as Head of Biologics by RIC, a world leading company providing analytical solutions (2019). Under her supervision, the department grew from four to fifteen staff members and was restructured in various operational units.

In 2021, she decided to start as an independent consultant, offering expertise in lead candidate selection, CMC and general pharmaceutical strategies, which are also her main responsibilities at 272Bio. She will mainly focus on the selection of new lead candidates towards commercial applications in animal health.